Trial Profile
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2024
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Anxiety disorders; Major depressive disorder; Mood disorders; Panic disorder
- Focus Therapeutic Use
- 19 Aug 2016 Planned number of patients changed from 2330 to 2530.
- 08 Jul 2014 Planned number of patients changed from 1890 to 2330 as reported by ClinicalTrials.gov.
- 17 Feb 2012 Planned number of patients changed from 1750 to 1890 as reported by ClinicalTrials.gov.